MPI/R01 Development Award
The purpose of this RFA is to stimulate the development of high-quality, multi-principal investigator (MPI) projects that will move forward to nationally-funded grant awards. Areas of thematic investigation are open, provided they maintain a clear cancer focus. Health disparities research from the bench to clinical, clinical to population/community level are encouraged. Projects with translational potential are preferred. In addition, a cross-cutting programmatic theme (cancer biology, translational oncology and population health) is encouraged. The cancer center leadership anticipates distributing two awards of $125,000(max) for one year. The one-year grant is available to all members (junior faculty must be independent investigators). A Letter of Intent (LOI) is required for this funding category, due March 01, 2019. LOIs will be reviewed and eligible applicants notified by March 08, 2019. Complete applications will be due April 10, 2019.
Funding: $125,000(max) for one year – Two Awards
Deadline: LOI due March 01, 2019; eligible applicants notified by March 08, 2019. Complete applications due April 10, 2019. Awardees notified by April 19. Funds will be released May 10, 2019 with approved IRB/IACUC.
For applicants invited to submit a full application, we strongly encourage Principal Investigators to submit IRB or IACUC.
V-Scholar Cancer Research Grant Program
The V Scholar Award supports early tenure-track faculty by funding a range of projects from laboratory- based fundamental research through bench to bedside research. The total amount of the grant is $200,000, paid in two annual installments of $100,000. Only direct costs of the research are supported by this award.
Deadline: LOI due by 5:00 PM on March 08, 2019; nominee will be notified on March 15, 2019
American Cancer Society Institutional Review Grant
The UI Cancer Center is applying for a prestigious American Cancer Society – Institutional Review Grant (ACS-IRG) due April 1, 2019. The ACS-IRG is designed to support the development of beginning investigators conducting cancer research by providing pilot funds to obtain preliminary results that will enable them to compete successfully for national research grants. The program is intended to support independent, self-directed, investigators early in their careers for whom the institution has committed research facilities, resources or space. The total annual grant award is $120,000 for up to 3 years and will support up to 5 awards annually at $30,000 each.
Deadline: Mentees interested submit LOI on March 08, 2019 by 5 PM.
Funding For Cancer Research
The PhRMA (Pharmaceutical Research and Manufacturers of America) Foundation is accepting applications for funding in Health Outcomes Research and Translational Medicine.
As a result of the Policy, Practice and Prevention Research Center’s (P3RC) funding from the CDC Prevention Research Center Program for
The Respiratory Health Association (RHA) is offering grants for Idiopathic Pulmonary Fibrosis ($25,000) and lung cancer ($50,000). The grants are typically